Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Lung Diseases and Rare Disorders

Is It a Lysosomal Storage Disease? Differential Diagnosis, Pathogenetic Mechanisms and Management

Bibliographic Data

ID15720109
AuthorsChiara Montanari (0000-0002-4875-6179, University of Milan), Veronica Maria Tagi (0000-0002-7001-9191, University of Milan), Enza D’Auria (0000-0003-2750-5810, University of Milan), Vincenzo Guaia (University of Milan), Anna Di Gallo (University of Milan), Michele Ghezzi (0000-0002-7434-9112, University of Milan), Elvira Verduci (0000-0003-2111-3111, University of Milan, corresponding author), L Fiori (0000-0003-3579-7403, University of Milan), Gianvincenzo Zuccotti (0000-0002-2795-9874, University of Milan)
Year2024
Volume11
Issue6
Pages668-668
Publication date2024-05-30
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children11060668
PMID38929247
OpenAlexW4399284319
LanguageEN
References cited106

Pulmonologists may be involved in managing pulmonary diseases in children with complex clinical pictures without a diagnosis. Moreover, they are routinely involved in the multidisciplinary care of children with rare diseases, at baseline and during follow-up, for lung function monitoring. Lysosomal storage diseases (LSDs) are a group of genetic diseases characterised by a specific lysosomal enzyme deficiency. Despite varying pathogen and organ involvement, they are linked by the pathological accumulation of exceeding substrates, leading to cellular toxicity and subsequent organ damage. Less severe forms of LSDs can manifest during childhood or later in life, sometimes being underdiagnosed. Respiratory impairment may stem from different pathogenetic mechanisms, depending on substrate storage in bones, with skeletal deformity and restrictive pattern, in bronchi, with obstructive pattern, in lung interstitium, with altered alveolar gas exchange, and in muscles, with hypotonia. This narrative review aims to outline different pulmonary clinical findings and a diagnostic approach based on key elements for differential diagnosis in some treatable LSDs like Gaucher disease, Acid Sphingomyelinase deficiency, Pompe disease and Mucopolysaccharidosis. Alongside their respiratory clinical aspects, which might overlap, we will describe radiological findings, lung functional patterns and associated symptoms to guide pediatric pulmonologists in differential diagnosis. The second part of the paper will address follow-up and management specifics. Recent evidence suggests that new therapeutic strategies play a substantial role in preventing lung involvement in early-treated patients and enhancing lung function and radiological signs in others. Timely diagnosis, driven by clinical suspicion and diagnostic workup, can help in treating LSDs effectively

Bronchopulmonary dysplasia · Differential diagnosis · Disease · Enzyme replacement therapy · Intensive care medicine · Lung · Lysosomal storage disease · Pathology · Pulmonary function testing · Pulmonologists · Cystic Fibrosis Research Advances · Family and Disability Support Research · Lysosomal Storage Disorders Research · Medicine · Internal Medicine · Pediatrics

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae